Chinyere Okoli
About
Chinyere Okoli is a scholar working on Infectious Diseases, Epidemiology and Virology.
According to data from OpenAlex, Chinyere Okoli has authored 28 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Chinyere Okoli's work include HIV/AIDS Research and Interventions (20 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (8 papers). Chinyere Okoli is often cited by papers focused on HIV/AIDS Research and Interventions (20 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (8 papers). Chinyere Okoli collaborates with scholars based in United Kingdom, United States and Nigeria. Chinyere Okoli's co-authors include Patricia Rios, Benjamin Young, Brent Allan, Nicolas Van de Velde, Giulio Maria Corbelli, Erika Castellanos, William D. Hardy, Marvelous Muchenje, Bruce W. Richman and Adaeze C. Ayuk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Preventive Medicine.
In The Last Decade
Chinyere Okoli
27 papers receiving 439 citations
Peers
Chinyere Okoli
Eduardo Matediana Mozambique
Heather Kirkham United States
Diana Nurutdinova United States
Amanda Su United States
Folasade B Adeniyi South Africa
Nurilign Abebe Moges Ethiopia
Veena G. Billioux United States
Lise Jamieson South Africa
Afshin Rastegar United States
Aparna Nishikant Shrotri India
Citations per year, relative to Chinyere Okoli Chinyere Okoli (= 1×)
peers
Eduardo Matediana
Countries citing papers authored by Chinyere Okoli
Since
Specialization
Citations
This map shows the geographic impact of Chinyere Okoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chinyere Okoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chinyere Okoli more than expected).
Fields of papers citing papers by Chinyere Okoli
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Chinyere Okoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chinyere Okoli. The network helps show where Chinyere Okoli may publish in the future.
Co-authorship network of co-authors of Chinyere Okoli
This figure shows the co-authorship network connecting the top 25 collaborators of Chinyere Okoli. A scholar is included among the top collaborators of Chinyere Okoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chinyere Okoli. Chinyere Okoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Moorhouse, Michelle, et al.. (2024). Associations between exposure to the U=U message and perceived HIV stigma among both the HIV and non-HIV adult populations in South Africa. SHILAP Revista de lepidopterología. 6(January). 1–17.
2.
Walmsley, Sharon, Don Smith, Miguel Górgolas, et al.. (2024). Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies. AIDS Research and Therapy. 21(1). 17–17.
3.
Katlama, Christine, Fiona Bisshop, Johannes R. Bogner, et al.. (2024). Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies. HIV Medicine. 25(7). 873–884.
4.
Grove, Richard, et al.. (2023). An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1. AIDS Research and Therapy. 20(1). 17–17.
5.
Yu, Fei, Yu‐Hsiang Hsiao, Brent Allan, et al.. (2022). The Influence of Anticipated HIV Stigma on Health-related Behaviors, Self-rated Health, and Treatment Preferences Among People Living with HIV in East Asia. AIDS and Behavior. 27(4). 1287–1303.
6.
Rios, Patricia, et al.. (2022). Preference for non-daily ART is associated with perceivedextent of ART-related emotional, psychosocial, physical, andadherence challenges among people living with HIV in theNetherlands and other European countries. SHILAP Revista de lepidopterología. 4(November). 1–13.
7.
Rios, Patricia, Chinyere Okoli, Erika Castellanos, et al.. (2021). Correction to: Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study. AIDS and Behavior. 25(9). 3045–3045.
8.
Okamoto, Noriko, et al.. (2021). Factors Associated with Treatment Satisfaction Among People Living with HIV in Japan and Other Selected Countries: Examination of the Intertwined Roles of Medication, Patient, and Provider Characteristics. AIDS and Behavior. 26(5). 1633–1651.
9.
Richman, Bruce W., Patricia Rios, Benjamin Young, et al.. (2021). 76. Effects of the “Undetectable = Untransmittable” (“U=U”) Educational Campaign on Treatment Outcomes and Perceptions among People Living with HIV in North American Countries. Open Forum Infectious Diseases. 8(Supplement_1). S49–S50.
10.
Okoli, Chinyere, Achim Schwenk, Stephen Taylor, et al.. (2021). Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens. International Journal of STD & AIDS. 32(12). 1165–1173.
11.
Okoli, Chinyere, Brent Allan, Erika Castellanos, et al.. (2020). Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV. AIDS and Behavior. 25(5). 1384–1395.
12.
Okoli, Chinyere, Nicolas Van de Velde, Bruce W. Richman, et al.. (2020). Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries. Sexually Transmitted Infections. 97(1). 18–26.
13.
Rios, Patricia, Chinyere Okoli, Yogesh Punekar, et al.. (2020). Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries. Preventive Medicine. 139. 106182–106182.
14.
Rios, Patricia, Chinyere Okoli, Erika Castellanos, et al.. (2020). Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study. AIDS and Behavior. 25(3). 961–972.
15.
Okoli, Chinyere, Nicolas Van de Velde, William D. Hardy, et al.. (2020). Differences in HIV treatment experiences, perceptions, and behaviors by gender and sexual orientation in 25 middle-income and high-income countries: Findings from the 2019 Positive Perspectives Survey. SHILAP Revista de lepidopterología. 2(December). 1–13.
16.
Ozoh, Obianuju B., et al.. (2020). Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria. Tropical Medicine & International Health. 26(1). 54–65.
17.
Okoli, Chinyere, et al.. (2020). Relationship Between Polypharmacy and Quality of Life Among People in 24 Countries Living With HIV. Preventing Chronic Disease. 17. E22–E22.
18.
Okoli, Chinyere, Nicolas Van de Velde, Brent Allan, et al.. (2020). Regional differences in perceived treatments needs and priorities in relation to antiretroviral therapy among people living with HIV in 25 countries. Preventive Medicine. 142. 106372–106372.
19.
Ayuk, Adaeze C., et al.. (2017). Spirometry in Asthma Care: A Review of the Trends and Challenges in Pediatric Practice. SHILAP Revista de lepidopterología. 11. 3879416419–3879416419.
20.
Okoli, Chinyere, Marco Siccardi, Jonathan Ainsworth, et al.. (2011). Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg. Journal of Antimicrobial Chemotherapy. 67(3). 671–674.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eduardo Matediana Breakdown of academic impact, for papers by Heather Kirkham Breakdown of academic impact, for papers by Diana Nurutdinova Breakdown of academic impact, for papers by Amanda Su Breakdown of academic impact, for papers by Folasade B Adeniyi Breakdown of academic impact, for papers by Nurilign Abebe Moges Breakdown of academic impact, for papers by Veena G. Billioux Breakdown of academic impact, for papers by Lise Jamieson Breakdown of academic impact, for papers by Afshin Rastegar Breakdown of academic impact, for papers by Aparna Nishikant Shrotri